SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001047469-13-009484
Filing Date
2013-10-03
Accepted
2013-10-02 21:28:15
Documents
7
Period of Report
2013-10-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a2216897z8-k.htm 8-K 24404
2 EX-99.1 a2216897zex-99_1.htm EX-99.1 360218
3 G807933.JPG g807933.jpg GRAPHIC 40533
4 G85016.JPG g85016.jpg GRAPHIC 35301
5 G946091.JPG g946091.jpg GRAPHIC 44398
6 G617211.JPG g617211.jpg GRAPHIC 34454
7 G301918.JPG g301918.jpg GRAPHIC 45855
  Complete submission text file 0001047469-13-009484.txt   662803
Mailing Address 9363 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9363 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 (514) 337-3333
Mirati Therapeutics, Inc. (Filer) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35921 | Film No.: 131132027
SIC: 2834 Pharmaceutical Preparations